Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Treasury Shares (2016 - 2019)

Historic Treasury Shares for Gyre Therapeutics (GYRE) over the last 9 years, with Q3 2019 value amounting to $1.6 million.

  • Gyre Therapeutics' Treasury Shares rose 1900.81% to $1.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.6 million, marking a year-over-year increase of 1900.81%. This contributed to the annual value of $821741.0 for FY2017, which is 48283.64% up from last year.
  • As of Q3 2019, Gyre Therapeutics' Treasury Shares stood at $1.6 million, which was up 1900.81% from $1.6 million recorded in Q2 2019.
  • Over the past 5 years, Gyre Therapeutics' Treasury Shares peaked at $1.6 million during Q2 2019, and registered a low of $44704.0 during Q1 2017.
  • Over the past 5 years, Gyre Therapeutics' median Treasury Shares value was $1.0 million (recorded in 2018), while the average stood at $920996.0.
  • Its Treasury Shares has fluctuated over the past 5 years, first tumbled by 7988.51% in 2015, then surged by 219597.58% in 2018.
  • Gyre Therapeutics' Treasury Shares (Quarter) stood at $103129.0 in 2015, then soared by 36.71% to $140990.0 in 2016, then skyrocketed by 482.84% to $821741.0 in 2017, then surged by 60.53% to $1.3 million in 2018, then increased by 19.01% to $1.6 million in 2019.
  • Its Treasury Shares stands at $1.6 million for Q3 2019, versus $1.6 million for Q2 2019 and $1.6 million for Q1 2019.